Crunching the numbers for SONM... Refresh in a moment for the full analysis.

DNA X, Inc. (SONM)

Technology weak

$2.97

Updated: 2026-04-13

TradeApes Score

reduce

Financial Strength

25 Stressed

Operating Trend

45 Mixed

Valuation

40 Weak

Capital Allocation

35 Weak

Risk

35 Weak

Key Findings

+ Net cash position — more cash on hand than total debt

− Weak interest coverage — earnings barely cover debt service

See the full analysis

Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.

Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.